Vessel-based Ultrasound Registration
Launched by THE NETHERLANDS CANCER INSTITUTE · Nov 24, 2022
Trial Information
Current as of May 18, 2025
Unknown status
Keywords
ClinConnect Summary
Image-guided navigation surgery allows for full utilization of pre-operative imaging during surgery and has the potential of reducing both irradical resections and morbidity. To use navigation, a registration procedure is required to correlate pre-operative imaging with the patient's position on the operating room (OR). Currently, registration is done by Cone-Beam CT (CBCT) scanning on the OR prior to navigation surgery. However, the main limitation of the CBCT method is that it cannot compensate for per-operative changes such as bed rotation, retractor placement and tissue displacement due...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 18 years old
- • Scheduled for laparotomy
- • A clinical pre-operative abdominal CT scan is available
- • Patient provides written informed consent
- Exclusion Criteria:
- • Metal implants in the pelvic area which could influence the 3D modelling or tracking accuracy
- • Patients with a pacemaker or defibrillator
- • Patient received pelvic-abdominal treatment, e.g. surgery or radiotherapy, between the pre-operative CT scan and laparotomy, which might altered the patient's anatomy
About The Netherlands Cancer Institute
The Netherlands Cancer Institute (NKI) is a leading research and treatment center dedicated to advancing the understanding and management of cancer. Renowned for its cutting-edge research, NKI fosters innovation in oncology through a multidisciplinary approach that integrates laboratory research, clinical trials, and patient care. With a commitment to translating scientific discoveries into effective therapies, the institute collaborates with national and international partners to enhance cancer treatment outcomes. NKI's state-of-the-art facilities and expertise in various cancer types position it as a pivotal contributor to the global fight against cancer, aiming to improve survival rates and quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amsterdam, North Holland, Netherlands
Patients applied
Trial Officials
Theo Ruers, prof. dr.
Principal Investigator
NKI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials